Chance Pharmaceuticals
Hangzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A pharma firm developing novel small molecule drugs for heart and metabolic diseases.
CardiovascularMetabolic
Technology Platform
Focuses on medicinal chemistry and small molecule drug discovery for cardiovascular and metabolic disease targets.
Opportunities
Addressing the enormous and growing patient burden of cardiovascular and metabolic diseases in China.
Risk Factors
Long development timelines and high risk of late-stage failure for novel small molecules in competitive indications.
Competitive Landscape
Competes in large, generic-dominated markets where demonstrating superior cost-effectiveness is as important as clinical benefit.